Josef S Smolen Selected Research

Josef S Smolen Research Topics

Disease

178	Rheumatoid Arthritis 10/2022 - 03/2002
41	Arthritis (Polyarthritis) 07/2022 - 01/2002
40	Necrosis 07/2022 - 04/2003
29	Psoriatic Arthritis 01/2022 - 07/2002
25	Rheumatic Diseases (Rheumatism) 01/2021 - 01/2007
25	Inflammation (Inflammations) 01/2019 - 03/2002
21	Pain (Aches) 11/2021 - 11/2002
20	Infections 01/2022 - 11/2004
17	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2002
9	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 03/2002
7	Fatigue 12/2020 - 03/2012
7	Ankylosing Spondylitis 11/2020 - 07/2002
6	Herpes Zoster 01/2022 - 01/2019
6	Lupus Nephritis 01/2020 - 10/2004
6	Joint Diseases (Joint Disease) 01/2020 - 04/2003
6	Neoplasms (Cancer) 01/2019 - 06/2010
6	Bone Resorption 01/2010 - 07/2002
5	Synovitis 01/2021 - 01/2008
5	Disease Progression 09/2019 - 11/2002
5	Pneumonia (Pneumonitis) 01/2017 - 11/2004
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2020 - 11/2012
4	Chronic Disease (Chronic Diseases) 09/2019 - 01/2017
3	Proteinuria 01/2020 - 10/2004
3	Osteoarthritis 01/2020 - 09/2007
3	Nephritis 01/2017 - 10/2004
3	Mixed Connective Tissue Disease (MCTD) 07/2011 - 08/2005
3	Systemic Scleroderma (Systemic Sclerosis) 05/2008 - 08/2005
2	Sacroiliitis 07/2022 - 03/2004
2	Experimental Arthritis 01/2020 - 01/2010
2	Hepatitis 01/2020 - 06/2011
2	Virus Diseases (Viral Diseases) 01/2019 - 11/2004
2	Alopecia (Baldness) 01/2019 - 06/2004
2	Arthralgia (Joint Pain) 01/2019 - 06/2015

Drug/Important Bio-Agent (IBA)

53	Methotrexate (Mexate)FDA LinkGeneric 10/2022 - 10/2004
43	Antirheumatic Agents (DMARD)IBA 01/2022 - 04/2002
38	Biological ProductsIBA 01/2022 - 08/2005
27	Adalimumab (Humira)FDA Link 01/2021 - 04/2003
27	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 03/2002
25	Infliximab (Remicade)FDA Link 12/2021 - 10/2004
19	baricitinibIBA 01/2022 - 01/2014
19	AutoantibodiesIBA 01/2019 - 03/2002
18	GlucocorticoidsIBA 01/2022 - 02/2005
17	tocilizumab (atlizumab)FDA Link 01/2022 - 12/2007
17	Biosimilar PharmaceuticalsIBA 01/2021 - 03/2013
17	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 01/2003
16	Etanercept (Enbrel)FDA Link 01/2020 - 05/2005
14	C-Reactive ProteinIBA 01/2022 - 07/2002
13	CytokinesIBA 07/2022 - 11/2002
11	Abatacept (Orencia)FDA Link 01/2021 - 07/2007
11	tofacitinibIBA 01/2021 - 01/2014
10	Rituximab (Mabthera)FDA Link 01/2021 - 07/2007
10	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 06/2004
10	golimumab FDA Link 01/2020 - 07/2009
9	ametantrone (HAQ)IBA 11/2021 - 04/2007
9	AntibodiesIBA 01/2021 - 08/2005
9	Certolizumab Pegol FDA Link 01/2020 - 11/2009
8	Janus Kinase InhibitorsIBA 01/2022 - 01/2017
7	Interleukin-6 (Interleukin 6)IBA 07/2022 - 03/2008
6	InterleukinsIBA 07/2022 - 06/2012
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2006
6	Rheumatoid FactorIBA 01/2018 - 11/2002
5	apremilastIBA 01/2022 - 01/2014
5	Ustekinumab (CNTO 1275)FDA Link 01/2022 - 09/2015
5	Janus KinasesIBA 10/2020 - 06/2017
5	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020 - 01/2005
5	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 06/2004
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2002
5	Prostaglandins AIBA 01/2020 - 09/2012
4	Interleukin-1 (Interleukin 1)IBA 07/2022 - 12/2003
4	Interleukin-12 (IL 12)IBA 01/2022 - 01/2005
4	Pharmaceutical PreparationsIBA 01/2022 - 05/2011
4	upadacitinibIBA 01/2021 - 12/2016
4	ixekizumabIBA 12/2020 - 01/2020
4	secukinumabIBA 01/2020 - 09/2015
4	ElementsIBA 08/2017 - 08/2007
4	Monoclonal AntibodiesIBA 03/2017 - 11/2004
4	CollagenIBA 01/2015 - 07/2002
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2013 - 12/2007
4	AutoantigensIBA 12/2007 - 03/2002
4	OsteoprotegerinIBA 02/2004 - 03/2002
3	amsonic acid (DAS)IBA 01/2020 - 11/2012
3	Anti-Citrullinated Protein AntibodiesIBA 01/2018 - 09/2010
3	pristane (pristan)IBA 01/2017 - 12/2007
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2008
3	Immunoglobulins (Immunoglobulin)IBA 06/2011 - 12/2007
3	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2006 - 07/2002
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2019
2	EnzymesIBA 01/2021 - 06/2004
2	Peptides (Polypeptides)IBA 01/2021 - 01/2010
2	Antinuclear AntibodiesIBA 01/2021 - 02/2016
2	clazakizumabIBA 01/2020 - 06/2017
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2019
2	guselkumabIBA 01/2020 - 05/2017
2	sarilumabIBA 01/2020 - 06/2017
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017

Therapy/Procedure

93	Therapeutics 10/2022 - 01/2002
6	Aftercare (After-Treatment) 11/2018 - 07/2009
3	Drug Therapy (Chemotherapy) 03/2012 - 07/2004
2	Drug Tapering 01/2019 - 01/2019